HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast cancer patients
Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease
Under the agreement Mylan will distribute Sovaldi and Harvoni in India
This transaction especially complements Mylan’s pending acquisition of Abbott’s non-US developed markets speciality and branded generics business